C71T
CANCELLED SECTION 71
04/24/2026
Back to search
Official data from USPTO
KANGHONG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
05/19/2026
Trademark type
Combined
Nice classes
5
Filing date
05/22/2018
Registration date
10/08/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/24/2026
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Sichuan, CN
Examiner
STINSON, JENNIFER ELLE
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of of a rounded chevron inside of a rectangle with rounded corners. To the right are two Chinese characters with a line underneath and the wording "KANGHONG" underneath the line.
Holders and representatives
Holders
Chengdu Kanghong Pharmaceuticals Group Co., Ltd.
Representatives
Jennifer Sheehan Anderson Bridge Intellectual Property Services
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Mothproofing preparations; Radioactive substances in the nature of drugs for medical purposes; Chemico-pharmaceutical preparations for reducing blood fat; Chemico-pharmaceutical preparations for promoting sleep; Chemico-pharmaceutical preparations for sedationanti-depressiontumor suppression; Chemico-pharmaceutical preparations for the treatment of diabetesdiseases of the central nervous systemdiseases of the respiratory systemcardiovascular diseases and cancer; Chemico-pharmaceutical preparations used in eye surgery and intraocular surgery; Pharmaceutical preparations in the nature of tissues impregnated with pharmaceutical skin lotions; Depuratives for the body; Media for bacteriological cultures; Medicinal preparations for the mouth to be applied in the form of tablets; Semen for artificial insemination; Medicines for human purposesmedicines for humans for the treatment or prevention of dermatologicalcardiovascularhematologicalbonerespiratorycentral nervous systemendocrinologicalcirculatorygastroenterologicalstomachdigestivehormonaldiabeticmuscularrheumaticimmune systemocular and metabolic diseases and disorders; Medicines for humans to treat or prevent diabetescoughscoldsinfluenzaheadaches and allergic reactions; Vermin destroying preparations; Biochemical drug for medical purposes for the treatment of cancer and ophthalmic diseases; Suppositories; Pharmaceutical preparations in the form of liquids for the treatment of central nervous system diseasestumorsdiabetesophthalmic diseases; Pharmaceutical preparations in the form of liquids for the treatment of cancer; Disinfectants for hygiene purposes; Mosquito-repellent incense; Sanitary sterilizing preparations in the nature of tissues impregnated with sterilization preparations; Chemical conductors for electrocardiograph electrodes; Dental lacquer; Medicinal drinks in the nature of herb liqueurs; Pharmaceutical preparations used for the relief of pain and to reduce fever; Pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseaseshemophiliametabolic diseasescancermultiple sclerosisurologic diseasessexual dysfunctionosteoporosisclimacteric diseases; Pharmaceutical preparationsanticoagulants and platelet aggregation inhibitors; anti-infective pharmaceutical preparations; Pharmaceutical preparationsophthalmics; Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions; Infusions for medical purposes for treating dermatological diseases; Gases for medical purposes; Wadding for medical purposes; Drugs for medical purposespharmaceutical preparations for anti-depressiontumor suppressionrelieving coughreducing blood pressure; Drugs for medical purposespharmaceutical preparations for the treatment central nervous system diseasesasthmadiabetesrespiratory system diseasescancercardiovascular diseasesgastrointestinal diseaseshyperlipidaemia and hypercholesteremia; Drugs for medical purposespharmaceutical preparations used in eye surgery and intraocular surgery; Bath preparations for medical purposes; Diagnostic agents for medical purposes; Solutions for contact lenses; Crude drugsnamely pharmaceutical preparations for the treatment of central nervous system diseasesnamely hypertensionhyperlipidemiaschizophrenia and melancholiadigestive system diseasesnamely dyspepsiachronic gastritischronic lithogenous cholecystitischronic cholecystitis and gall-stoneophthalmology system diseasesnamely wet Age-related Macular Degeneration (AMD)other diseasesnamely feverirritabilityred eyesmouth soressore throatswollen gumsconstipationpharyngitistonsillitisgingivitisupper respiratory infection (URI)acute bronchitisdiabetes and nephropathy; Pharmaceutical preparations in the form of injections for the treatment of central nervous system diseasesdiabetesfundus oculi disease and cancer; Pharmaceutical preparations in the form of injections for tumor suppression; Pharmaceutical preparations in the form of injections used in eye surgery and intraocular surgery; Traditional Chinese medicines for Chinese medicinal usedried Chinese boxthorn fruitsChinese-datepseudo-ginsengChinese angelica and ginseng; Traditional Chinese medicines for Chinese medicinal usedried Chinese boxthorn fruitsChinese-datepseudo-ginsengChinese angelica and ginseng sold as a kit in a Chinese medicine bag
Publications
History of USPTO decisions and trademark events.
31 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/08/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/09/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/10/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/10/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/10/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/10/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/10/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/10/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/13/2020
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
02/03/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
02/03/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/08/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
10/08/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/23/2019
PUBO
PUBLISHED FOR OPPOSITION
07/23/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/03/2019
ALIE
ASSIGNED TO LIE
06/14/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/31/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/09/2019
RFNT
REFUSAL PROCESSED BY IB
12/28/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/13/2018
RFRR
REFUSAL PROCESSED BY MPU
12/13/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/30/2018
CNRT
NON-FINAL ACTION WRITTEN
11/29/2018
MAFR
APPLICATION FILING RECEIPT MAILED
11/27/2018
DOCK
ASSIGNED TO EXAMINER
11/23/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/23/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/22/2018
Continuous trademark protection
Get notified about every new filing that threatens KANGHONG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.